Cardiolipin synthase (cls) enzymes catalyze the final step in CL biosynthesis, which varies across organisms:
Bacterial Mechanism:
Citrobacter koseri cls likely follows the bacterial Type I mechanism, as inferred from its classification in the phospholipase D superfamily .
CL is essential for maintaining membrane curvature, proton gradient stability, and virulence in pathogens. For example:
In Staphylococcus aureus, CL depletion via cls1 and cls2 deletion reduces cytotoxicity to neutrophils and virulence in mouse models .
In E. coli, CL synthesis is regulated by osmolarity and growth phase, with three distinct cls genes (clsA, clsB, clsC) ensuring redundancy .
The recombinant C. koseri cls protein is used in:
ELISA Assays: Detection of anti-cls antibodies in research or diagnostic settings .
Biochemical Studies: Characterization of CLS activity, substrate specificity, and inhibition kinetics.
Structural Biology: Crystallization and X-ray diffraction studies to elucidate active-site architecture.
Mechanistic Gaps: The precise catalytic mechanism of C. koseri cls remains uncharacterized, necessitating in vitro assays to confirm substrate preferences.
Pathogenicity Links: Investigating whether CLS inhibition impacts C. koseri virulence, as seen in S. aureus .
Therapeutic Potential: Exploring CLS as a drug target for antimicrobial development, given CL’s role in bacterial membrane integrity.
KEGG: cko:CKO_01326
STRING: 290338.CKO_01326